stockrow
Friday 6 November 2026
Export USNA’s income statement to Excel — free account
USANA Health Sciences, Inc.
USNA Consumer Defensive Packaged Foods
USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024.
- Revenue
- −3.64%
- EPS
- −3.47%
- Free cash flow
- +180.6%
Quarter to September 2026, against a year earlier
13.58
0.28
−2.02%
Follow USNA
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 5 | 6 | 7 |
+8 more TTM periods Free account |
| 0.00% | (4.19%) | 1.65% | 2.02% | ||
| (2.95%) | (3.08%) | 1.19% | 1.44% | ||
ROIC |
(0.67%) | (0.19%) | 5.85% | 6.24% | |
Return on Tangible Assets |
(7.78%) | (8.22%) | 3.27% | 4.23% | |
Average Days of Receivables |
2.03 | 1.33 | 3.81 | 1.69 | |
Free Cash Flow per Share |
0.00 | 1.08 | 0.38 | 0.67 | |
Free Cash Flow |
— | 19.90 | 6.91 | 12.43 | |
Capital Expenditures |
— | (7.82) | (9.71) | (9.92) | |
| Other line items | |||||
Cash ROIC |
0.00% | 2.86% | 0.98% | 1.80% | |
Accounts Receivable Turnover |
147.98 | 173.97 | 108.44 | 141.83 | |
Accounts Payable Turnover |
12.15 | 12.36 | 13.76 | 13.73 | |
Inventory Turnover |
2.36 | 2.43 | 2.45 | 2.33 | |
Average Days of Payables |
31.31 | 27.34 | 28.50 | 31.37 | |
Days of Inventory on Hand |
149.05 | 152.99 | 169.22 | 186.47 | |
Tax Rate |
474.44 | (12.53) | (0.77) | (0.72) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
73.69% | 73.61% | 72.95% | 73.49% | |
Share Based Compensation of Revenue |
0.00% | 1.55% | 1.56% | 1.49% | |
Interest Coverage |
(8.34) | — | 53.11 | 44.46 | |
Operating CF/Net income |
0.00 | (1.25) | 1.87 | 2.08 | |
Depreciation/Fixed assets |
0.00 | 0.72 | 0.41 | 0.42 | |
Capex/Depreciation |
— | (0.12) | (0.25) | (0.25) | |
Revenue per Share |
48.96 | 49.41 | 50.33 | 49.92 | |
Operating CF per Share |
0.00 | 1.50 | 0.90 | 1.21 | |
Capex per Share |
0.00 | (0.42) | (0.53) | (0.54) | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026